
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glia-specific APOE epigenetic changes in the Alzheimer’s disease brain
Jessica Tulloch, Lesley Leong, Zachary Thomson, et al.
Brain Research (2018) Vol. 1698, pp. 179-186
Open Access | Times Cited: 48
Jessica Tulloch, Lesley Leong, Zachary Thomson, et al.
Brain Research (2018) Vol. 1698, pp. 179-186
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Hannah Chew, Victoria Solomon, Alfred N. Fonteh
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 269
Hannah Chew, Victoria Solomon, Alfred N. Fonteh
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 269
ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 215
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 215
Solving neurodegeneration: common mechanisms and strategies for new treatments
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 196
Lauren K. Wareham, Shane A. Liddelow, Sally Temple, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 196
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Xiaolei Liu, Bin Jiao, Lu Shen
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 134
Xiaolei Liu, Bin Jiao, Lu Shen
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 134
Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease
Makis Tzioras, C. T. M. Davies, Andrew J. Newman, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 4, pp. 327-346
Open Access | Times Cited: 119
Makis Tzioras, C. T. M. Davies, Andrew J. Newman, et al.
Neuropathology and Applied Neurobiology (2018) Vol. 45, Iss. 4, pp. 327-346
Open Access | Times Cited: 119
Neurodevelopmental toxicity induced by PM2.5 Exposure and its possible role in Neurodegenerative and mental disorders
X. Liu, Jia Huang, Chao Song, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 29
X. Liu, Jia Huang, Chao Song, et al.
Human & Experimental Toxicology (2023) Vol. 42
Open Access | Times Cited: 29
Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
Laura M. De Plano, Alessandra Saitta, Salvatore Oddo, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 719-719
Open Access | Times Cited: 15
Laura M. De Plano, Alessandra Saitta, Salvatore Oddo, et al.
Cells (2024) Vol. 13, Iss. 8, pp. 719-719
Open Access | Times Cited: 15
regionalpcs improve discovery of DNA methylation associations with complex traits
Tiffany Eulalio, Min Sun, Olivier Gevaert, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Tiffany Eulalio, Min Sun, Olivier Gevaert, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Uncovering the epigenetic regulatory clues of PRRT1 in Alzheimer’s disease: a strategy integrating multi-omics analysis with explainable machine learning
Fang Wang, Ying Liang, Qinwen Wang
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Fang Wang, Ying Liang, Qinwen Wang
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Epigenetic mechanisms of neurodegenerative diseases and acute brain injury
Mario J. Bertogliat, Kahlilia C. Morris-Blanco, Raghu Vemuganti
Neurochemistry International (2019) Vol. 133, pp. 104642-104642
Open Access | Times Cited: 55
Mario J. Bertogliat, Kahlilia C. Morris-Blanco, Raghu Vemuganti
Neurochemistry International (2019) Vol. 133, pp. 104642-104642
Open Access | Times Cited: 55
Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer’s disease
Abhishek Ankur Balmik, Subashchandrabose Chinnathambi
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Abhishek Ankur Balmik, Subashchandrabose Chinnathambi
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 52
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 19
Danko Jeremic, Lydia Jiménez‐Díaz, Juan D. Navarro‐López
Ageing Research Reviews (2023) Vol. 90, pp. 102003-102003
Closed Access | Times Cited: 19
Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
Bhanu Chandra Karisetty, Akanksha Bhatnagar, Ellen M. Armour, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 49
Bhanu Chandra Karisetty, Akanksha Bhatnagar, Ellen M. Armour, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 49
Metabolic disorder in Alzheimer’s disease
Mrinal K. Poddar, Soumyabrata Banerjee, Apala Chakraborty, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 781-813
Closed Access | Times Cited: 38
Mrinal K. Poddar, Soumyabrata Banerjee, Apala Chakraborty, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 781-813
Closed Access | Times Cited: 38
APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
Anna Yang, Boris Kantor, Ornit Chiba‐Falek
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1244-1244
Open Access | Times Cited: 34
Anna Yang, Boris Kantor, Ornit Chiba‐Falek
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1244-1244
Open Access | Times Cited: 34
Epigenetic Modifications and Neurodegenerative Disorders: A Biochemical Perspective
Xiaoxiao Zhang, Jiaming Zhang, Yuchuan Wang, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 2, pp. 177-184
Closed Access | Times Cited: 26
Xiaoxiao Zhang, Jiaming Zhang, Yuchuan Wang, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 2, pp. 177-184
Closed Access | Times Cited: 26
A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2975-2975
Open Access | Times Cited: 25
Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2975-2975
Open Access | Times Cited: 25
Epigenetic Regulation of Neuroinflammation in Alzheimer’s Disease
Yajing Ma, Wang Wang, Sufang Liu, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 14
Yajing Ma, Wang Wang, Sufang Liu, et al.
Cells (2023) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 14
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
Xuewen Xiao, Xixi Liu, Bin Jiao
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 38
Xuewen Xiao, Xixi Liu, Bin Jiao
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 38
DOENÇA DE ALZHEIMER E SEUS MECANISMOS EPIGENÉTICOS
Barbara Arruda Salgado, Catarina Borges López Monteiro Francisco, Melinda González Concepción, et al.
Revista Foco (2025) Vol. 18, Iss. 3, pp. e7536-e7536
Open Access
Barbara Arruda Salgado, Catarina Borges López Monteiro Francisco, Melinda González Concepción, et al.
Revista Foco (2025) Vol. 18, Iss. 3, pp. e7536-e7536
Open Access
APOE, Pesticides, Environmental Pollutants, and Epigenetics
Judit Biosca-Brull, María Teresa Colomina, María Cabré, et al.
(2025), pp. 1-39
Closed Access
Judit Biosca-Brull, María Teresa Colomina, María Cabré, et al.
(2025), pp. 1-39
Closed Access
DNA methylation in genes associated with the evolution of ageing and disease: A critical review
Mark T. Mc Auley
Ageing Research Reviews (2021) Vol. 72, pp. 101488-101488
Closed Access | Times Cited: 21
Mark T. Mc Auley
Ageing Research Reviews (2021) Vol. 72, pp. 101488-101488
Closed Access | Times Cited: 21
Integrative single-nucleus multi-omics analysis prioritizes candidate cis and trans regulatory networks and their target genes in Alzheimer’s disease brains
Julia Gamache, Daniel Gingerich, E. Keats Shwab, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Julia Gamache, Daniel Gingerich, E. Keats Shwab, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease
Madia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1529-1529
Open Access | Times Cited: 9
Madia Lozupone, Vittorio Dibello, Rodolfo Sardone, et al.
Biology (2023) Vol. 12, Iss. 12, pp. 1529-1529
Open Access | Times Cited: 9